Stockreport

Annovis To Present at the 2025 Annual Meeting of the Parkinson Study Group

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering tra [Read more]